We assessed BM cell migration in the presence or absence of a CCL2 production inhibitor, bindarit, in tumor/stroma cocultures (HSC-2 + HDF, HSC-2 + PDS1, and HSC-2 + PDS2) (Figure 5A). The gene discussed is CCL2; the disease is neoplasm.